New investment set to improve healthspan outcomes from birth

LongeVC investment in healthtech startup Melio’s rapid blood testing platform will improve longevity diagnostics – and quality of life.
LongeVC, a VC backing early-stage breakthrough technologies, announced today that it has invested in Melio, a health technology startup pio…Read More

Koneksa and Beacon Biosignals join forces on neuro biomarkers

Digital biomarkers company Koneksa and computational neurodiagnostics firm Beacon Biosignals have partnered to conduct a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into Koneksa’s Neuroscience Solution Toolkit.

Beacon’s platf…Read More

Dialing up human longevity

Lifeforce CEO on the benefits of delivering longevity medicine via telehealth.
Earlier this year, US personalized health and longevity company Lifeforce landed $12 million in Series A funding from investors including M13 and Peterson Ventures. The new funding follows seed investment from co-founders Tony Robbins and…Read More

New blood test detects key indicator of Parkinson’s disease

Blood test that detects Parkinson’s disease could establish a way to help diagnose the debilitating condition before damage to the nervous system worsens.
A new blood-based diagnostic test could be a major advancement for the treatment of Parkinson’s, a disease that afflicts 10 milli…Read More

New panel set to aid detection of inflammation and biological stress biomarkers

Metabolon’s new Biological Stress Discovery Panel will provide insights into biological stress pathways and enable personalized solutions.
Metabolon, Inc, a company providing metabolomics solutions that advance wide variety of research, diagnostic, therapeutic d…Read More

FDA clears AI tool for early Alzheimer’s detection from MRI scans

AIRAmed receives FDA 510(k) clearance for AI-powered brain volumetry software.
German medtech company AIRAmed has received FDA 510(k) clearance for its AIRAscore brain volumetry software that supports early detection of Alzheimer’s disease and other forms of dementia. The sof…Read More

Aqtual bags $16m for precision medicine platform, initiates rheumatoid arthritis trial

Liquid biopsy platform measures epigenetics, gene regulation, and transcriptomics by analyzing cell-free DNA from a single blood draw.
Precision medicine company Aqtual has secured $16 million in Series A funding, co-led by Genoa Ventures, Manta Ray…Read More

Over 30? Time to get proactive about health, longevity and disease prevention

Why taking a proactive approach to longevity means being out for blood.
As individuals transition into their 30s, the body begins to experience subtle shifts that can significantly impact long-term health and wellness. This pivotal phase heralds a time where…Read More

Longevity means taking a proactive approach to prevention

Is your health at its best? Discover how Lifeforce can tell.
Embracing proactive health strategies is crucial for enhancing longevity – this approach to wellness involves taking informed steps to prevent diseases before they manifest, and is rooted in the understanding that early d…Read More